TAILOR achieves clinical success with phage therapy

A patient in a hospital develops an antibiotic-resistant bacterial infection that is untreatable or only treatable with the most toxic of antibiotics. During the 48 hours it takes to identify the bacterial species and strain, physicians and scientists also screen a library of bacterium-killing viruses or bacteriophages at hand, select those that are effective against this antibiotic-resistant bacterial strain and mix a personalized cocktail of phages to successfully treat the patient.

Know more: Only a few years have passed, but now Dr. Anthony Maresso, professor of molecular virology and microbiology, and his colleagues have turned this possibility into a reality in a clinical setting. The team has developed TAILOR — Tailored Antibacterials and Innovative Laboratories for phage (Φ) Research — a Baylor College of Medicine initiative that provides personalized therapeutic solutions for infectious diseases.

Source: blogs.bcm.edu